Graham Clarke was CEO of ImmBio from 2006-2017, establishing the company, its development portfolion and securing investment, grants and licenses. He is currently a Board Director of the UK's Health Reseach Authority and Board Chair at NHS HUC.
Graham was previously Vice President of Marketing Operations in Strategic Product Management for SmithKline Beecham, then head of Executive Decision Support, GSK R&D (on GW and SB merger) and latterly led Strategic Development for GE Healthcare Biosciences (formerly Amersham plc). He was a Partner in the PA Consulting Groups’ Pharmaceutical & Biotechnology practice. He has a master’s degree in biophysics, an MBA and is also qualified as a chartered management accountant.